NO promotes pancreatic cancer cell proliferation, and this effect can be dampened by knocking down NOS3 activity in KRAS mutant tumors.176 Arg deprivation is currently being evaluated for safety and efficacy in clinical trials. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.